{
 "slug": "found",
 "name": "Found",
 "website": "https://joinfound.com",
 "category": "telehealth",
 "model": "membership-plus-medication",
 "medications": {
  "semaglutide": true,
  "tirzepatide": true,
  "brand": true,
  "oral": true
 },
 "membership_fee_monthly": 49,
 "shipping": "paid",
 "consultation": "included",
 "consultation_fee": 0,
 "dose_based_pricing": false,
 "price_lock": false,
 "commitment": "month-to-month membership",
 "cancellation": "Cancel anytime",
 "pharmacy_type": "503A (provider-stated; pharmacy not named)",
 "pharmacies": [],
 "states_served": "all-50",
 "states_excluded": [],
 "insurance_support": true,
 "support_247": false,
 "care_model": "Program membership with clinician visits, health coaching and app; medication billed separately through insurance or cash",
 "verification_status": "reported",
 "last_verified": "2026-08-02",
 "advertised_price": {
  "tirzepatide": 149,
  "semaglutide": 99
 },
 "pros": [
  "Broad medication menu including brand-name and non-GLP-1 options",
  "Coaching and behavior-change program included",
  "Insurance support for brand medication"
 ],
 "cons": [
  "Membership is separate from medication, so the advertised price understates the monthly total",
  "Medication pricing pending verification"
 ],
 "best_for": "Patients who want a coaching-heavy program and may qualify for insurance-covered brand medication",
 "verification_note": "Found's site advertises compounded GLP-1 treatment from $99 plus membership/program options from $49; its tirzepatide store page supports a $149 first-month offer, while the $359 renewal figure rests on a third-party directory. Found says it works with licensed 503A pharmacies without naming them. Verified against the provider's own pages on 2026-08-25 (first-party verification pass).",
 "url": "https://glp1telehealthreviews.com/providers/found/",
 "plans": [
  {
   "medication": "semaglutide",
   "protocol": "standard",
   "form": "injection",
   "term_months": 1,
   "price_per_month": null,
   "maintenance_price_per_month": null,
   "all_inclusive": false,
   "dose_note": "\"From $99\" compounded GLP-1 treatment plus membership/program options from $49; not a standard recurring all-in price.",
   "source_url": "https://joinfound.com/",
   "last_verified": null,
   "status": "unverified",
   "true_monthly": null,
   "flags": [
    "price unknown"
   ],
   "true_monthly_maintenance": null,
   "annual_total": null,
   "annual_flags": [
    "price unknown"
   ],
   "first_month_total": null
  },
  {
   "medication": "tirzepatide",
   "protocol": "standard",
   "form": "injection",
   "term_months": 1,
   "price_per_month": 359,
   "maintenance_price_per_month": 359,
   "all_inclusive": false,
   "dose_note": "$149 for the first month is supported by Found's store page; the $359 renewal figure comes from a third-party directory (checked August 2, 2026) and was not found on an authoritative checkout page. Membership from $49 per month is billed separately.",
   "source_url": "https://joinfound.com/store/compounded-tirzepatide",
   "last_verified": "2026-08-02",
   "status": "reported",
   "intro_price_per_month": 149,
   "intro_months": 1,
   "true_monthly": 408.0,
   "flags": [
    "shipping billed separately (amount not modeled)"
   ],
   "true_monthly_maintenance": 408.0,
   "annual_total": 4686.0,
   "annual_flags": [
    "shipping billed separately (amount not modeled)",
    "introductory price for the first 1 month"
   ],
   "first_month_total": 198.0
  }
 ],
 "summary": {
  "tirzepatide": {
   "medication": "tirzepatide",
   "m2m_start": 408.0,
   "m2m_maint": 408.0,
   "lowest_start_true": 408.0,
   "lowest_first_month": 198.0,
   "best_annual": 4686.0,
   "best_annual_monthly": 390.5,
   "advertised": 149,
   "status": "reported",
   "flags": [
    "introductory price for the first 1 month",
    "shipping billed separately (amount not modeled)"
   ]
  },
  "semaglutide": null
 },
 "value_score": {
  "total": 58,
  "cost": 14.4,
  "transparency": 17,
  "flexibility": 15,
  "care": 6,
  "verification": 6,
  "provisional": false
 },
 "generated": "2026-08-25"
}